Hepln-13

CAS No. 64369-13-7

Hepln-13( Hepln 13 | Hepln13 )

Catalog No. M24659 CAS No. 64369-13-7

Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 115 In Stock
10MG 192 In Stock
25MG 385 In Stock
50MG 575 In Stock
100MG 801 In Stock
500MG 1647 In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Hepln-13
  • Note
    Research use only, not for human use.
  • Brief Description
    Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.
  • Description
    Hepln-13 is a hepsin inhibitor that acts by hindering prostate cancer bone metastasis.
  • In Vitro
    Hepln-13 (10 μM; 2 hours; 293 cells) inhibits cleavage.Western Blot Analysis Cell Line:293 cells Concentration:10 μM Incubation Time:2 hours Result:Inhibited cleavage.
  • In Vivo
    HepIn-13 displays dose dependent inhibition of Hepsin overexpression-relevant prostate cancer phenotypes and blocks prostate cancer metastasis.
  • Synonyms
    Hepln 13 | Hepln13
  • Pathway
    Angiogenesis
  • Target
    c-Met/HGFR
  • Recptor
    hepsin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    64369-13-7
  • Formula Weight
    325.2
  • Molecular Formula
    C17H13BrN2
  • Purity
    >98% (HPLC)
  • Solubility
    DMSO:60 mg/mL?(184.50 mM;?Need ultrasonic)
  • SMILES
    Brc1ccc(C(N2)Nc3cccc4cccc2c34)cc1
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1.Tang X, et al. Targeted inhibition of cell-surface serine protease Hepsin blocks prostate cancer bone metastasis. Oncotarget. 2014;5(5):1352-1362.
molnova catalog
related products
  • JNJ-38877605

    JNJ-38877605 is a potent, selective, ATP-competitive inhibitor of catalytic activity c-Met with IC50 of 4 nM.

  • AHU377 calcium salt

    AHU-377 hemicalcium salt is a potent NEP inhibitor with an IC50 of 5 nM. AHU-377 is a component of the heart failure medicine LCZ696.AHU377 is a prodrug of LBQ657.

  • Grazoprevir

    MK-5172 is a selective inhibitor of Hepatitis C virus NS3/4a protease with broad activity across genotypes and resistant variants, with Ki of 0.01 nM (gt1a), 0.08 nM (gt2a), 0.90 nM (gt3a), 0.01 nM (gt1b), 0.15 nM (gt2b), respectively.